Natriuretic peptides, brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of
brain natriuretic peptide (NT-proBNP) are globally and most often used for the diagnosis of …

Heart failure (HF) is a clinical syndrome with symptoms and or signs caused by a structural
and/or functional cardiac abnormality and associated with elevated natriuretic peptide levels …

Background US guidelines recommend consideration of sacubitril/valsartan in chronic heart
failure (HF) and mildly reduced or preserved ejection fraction (EF). Whether initiation is safe …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a global health care problem,
with diagnostic difficulty, limited treatment options and high morbidity and mortality rates …

Enhancing access to care using telehealth is a priority for improving outcomes among older
adults with heart failure, increasing quality of care, and decreasing costs. Telehealth has the …

Nutrition in the cardiovascular field to date has focused on improving lifestyle-related
diseases such as hypertension and diabetes from the viewpoint of secondary prevention …

Simple Summary CNP is the third natriuretic peptide to be isolated and is widely expressed
in the central nervous system, osteochondral system, and vascular system. The receptor that …

Congestive heart failure produces fluid volume overload, central and renal venous pressure
elevation, and consequently renal congestion, which results in worsening renal function …

There is limited data on whether diastolic dysfunction in patients with heart failure (HF) and
recovered ejection fraction (HFrecEF) is associated with worse prognosis. We …

Mitral regurgitation (MR), among the most common valvular heart diseases, is closely
associated with heart failure and worse clinical outcomes. Surgical repair or replacement as …